<DOC>
	<DOC>NCT00454090</DOC>
	<brief_summary>The primary purpose of this protocol is to investigate the safety and tolerability of AZD8330 (ARRY-424704) in patients with Advanced Malignancies</brief_summary>
	<brief_title>AZD8330 First Time in Man in Patients With Advanced Malignancies</brief_title>
	<detailed_description />
	<criteria>Cancer which is refractory to standard therapies, or no therapies exist; Participated in radiotherapy, biological or chemotherapy within 21 days prior to study start; Hasn't participated in investigation drug study within 30 days; Brain metastases/spinal cord compression unless treated and stable, Off steroids/anticonvulsants.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Advanced Malignancies</keyword>
</DOC>